Creo Medical Group PLC

Research Creo Medical Group PLC (CREO) on Bullrun: market cap GBX 6.56B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCREO
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryMedical Devices
• CurrencyGBX
• Market capGBX 6.56B
• Financial periodFY2024
• RevenueGBP 4.00M
• Revenue growth0.0%
• Net income-GBP 28.70M
• Free cash flow-GBP 22.60M
• Gross margin47.5%

Valuation Snapshot

latest market cap is GBX 6.56B.

About Creo Medical Group PLC

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy;

Frequently asked questions

What is Creo Medical Group PLC's market cap?

Creo Medical Group PLC's market capitalization is GBX 6.56B.

What does Creo Medical Group PLC do?

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom.